Research Paper Volume 13, Issue 20 pp 23517—23526
A genetic determinant of VEGF-A levels is associated with telomere attrition
- 1 Université de Lorraine, IGE-PCV, Nancy F-54000, France
- 2 Université de Lorraine, Inserm, DCAC, Nancy F-54000, France
- 3 Randox Laboratories Limited, Crumlin, Co. Antrim BT29 4QY, Northern Ireland, United Kingdom
- 4 Université de Lorraine, CHRU-Nancy, Pôle “Maladies du Vieillissement, Gérontologie et Soins Palliatifs”, Nancy F-54000, France
Received: March 18, 2021 Accepted: October 3, 2021 Published: October 18, 2021https://doi.org/10.18632/aging.203636
How to Cite
Copyright: © 2021 Gorenjak et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Telomere length (TL) is a hallmark of cellular aging and is associated with chronic diseases development. The vascular endothelial growth factor A (VEGF-A), a potent angiogenesis factor, is implicated in the pathophysiology of many chronic diseases. The aim of the present study was to investigate the associations between VEGF-A and TL.
TL in leukocytes (LTL) and skeletal muscle (MTL) were measured, 10 VEGF-related polymorphisms genotyped, and VEGF-A plasma concentrations determined in 402 individuals from the TELARTA cohort. LTL/MTL ratio was calculated as an estimate of lifelong TL attrition. Associations between VEGF-A variants and levels, and TL parameters were investigated.
We identified one significant association between the minor allele (T) of rs6993770 variant and LTL/MTL ratio (P=0.001143, β=0.0148, SE=0.004516). The rs6993770 is an intronic variant of the ZFPM2 gene, which is involved in haematopoiesis and the identified association with increased telomere attrition could be due to increased haematopoiesis. No significant epistatic interaction was identified, and no association was found between levels of VEGF-A and any of assessed phenotypes.
We identified a potential common genetic regulation between VEGF-A and telomere length attrition that could be explained by mechanisms of increased hematopoiesis and production of platelets. VEGF-A and TL could play an important role in personalized medicine of chronic diseases and identification of molecular links between them can promote the understanding of their complex implications.
CVD: Cardiovascular disease; CVD: Cardiovascular diseases; FDA: Food and Drug Administration; FOG: Friend of GATA; GWAS: Genome-wide association study; HDL: High-density lipoproteins; HWE: Hardy-Weinberg equilibrium; IL: Interleukin; LTL: Leukocyte telomere length; MAF: Minor allele frequency; MTL: Muscle telomere length; SE: Standard error; SNP: Single nucleotide polymorphism; TL: Telomere length; VEGF-A: Vascular endothelial growth factor A; ZFP: Zinc finger protein.